SC trastuzumab cost-saving for HER2-positive breast cancer in Hong Kong
A
cost minimization analysis based on a literature review and Hong Kong
data suggests that using subcutaneous (CS) instead of intravenous
(IV) ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.